Search Results

Breakthrough research models mitochondrial disorders in mice, revealing potential for targeted therapies and deeper genetic understanding

India strengthens its gene editing and cell therapy ecosystem under the BioE3 policy, with CRISPR guidelines and progress in hemophilia gene therapy

Early-phase clinical trial evaluates CRISPR-based gene editing therapy for sustained LDL cholesterol and triglyceride reduction.

GlowCas9 lights up while editing genes, allowing scientists to track CRISPR activity in living cells safely and accurately.

Breakthrough CRISPR treatment shows dual reductions in LDL and triglycerides in early human trial.

UTSW findings could lead to therapies for rare syndrome linked to inherited vascular conditions, other health problems